Research Study

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
Principal Investigator 
Lori Tucker

Overview

Body Locations and Systems 
Juvenile Rheumatoid Arthritis
ClinicalTrials.gov# 
NCT01357668
Status 
Recruiting
Study Start/End 
Jan 15, 2014 to Mar 26, 2030
Locations 
Mary Pack Arthritis Centre
Name/Title 
Felice Mizan, Study Coordinator
Phone 
604-875-2000 ext.4839
Email Address 
felice.mizan@cw.bc.ca
Purpose of Study 

The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis (JIA) with particular in interest in the occurrence of serious infections, autoimmune disorders, and malignancies.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.